Entacapone
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Catechol-O-Methyltransferase Inhibitor
Rising Pharma Holdings, Inc.
Listed by Alembic Pharmaceuticals Limited
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Catechol-O-Methyltransferase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 46708-478 |
| FDA application | ANDA212601 |
| RxNorm concept | 317094 |
| Package sizes listed | 2 |
| Marketed since | January 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Rising Pharma Holdings, Inc.
Lannett Company, Inc.
Aurobindo Pharma Limited
NCS HealthCare of KY, LLC dba Vangard Labs
Major Pharmaceuticals
Sandoz Inc
Aphena Pharma Solutions - Tennessee, LLC
American Health Packaging
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.